2025-08-08 - Analysis Report
Okay, here's the report on Transmedics Group Inc (TMDX), incorporating the data you provided, with analysis and explanations.

**Transmedics Group Inc (TMDX) Stock Analysis**

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** TMDX
*   **Company Overview:** Transmedics Group Inc. focuses on developing and delivering technologies for preserving organs for transplant.
*   **TMDX Cumulative Return:** 221.24%
*   **VOO Cumulative Return:** 71.50%
*   **Absolute Divergence (TMDX - VOO):** 149.74%
*   **Relative Divergence:** (Max: 296.4, Min: -64.2, Current: 168.6, Relative Divergence: 64.6)

**Analysis:** TMDX has significantly outperformed the S&P 500 (VOO) over the period examined.  The absolute difference in cumulative returns is substantial. The relative divergence of 64.6 indicates that the current divergence is positioned in the upper-middle range of its historical divergence.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta | Cap(B) |
| :----------- | :------ | :------ | :------ | :--- | :----- |
| 2019-2021  | -4.0%   | 63.4% | -52.0%  | 0.1  | 0.7   |
| 2020-2022  | 140.0%  | 68.3% | 133.0%  | 0.2  | 2.1   |
| 2021-2023  | 95.0%   | 69.4% | 75.0%   | 0.4  | 2.7   |
| 2022-2024  | 147.0%  | 82.8% | 120.0%  | 0.4  | 2.1   |
| 2023-2025  | 102.0%  | 82.8% | 55.0%   | 0.6  | 4.0   |

*   **CAGR (Compound Annual Growth Rate):** Varies significantly, reflecting periods of both negative and very strong growth.
*   **MDD (Maximum Drawdown):** High MDD values indicate significant volatility and risk.
*   **Alpha:**  Generally positive and high, suggesting TMDX has generated returns above what would be expected based on market movements (S&P 500).  The negative alpha for 2019-2021 is a clear outlier.
*   **Beta:**  High beta values suggest that TMDX is more volatile than the S&P 500.

**2. Recent Stock Price Movement**

*   **Current Price:** 116.05
*   **Last Market Close:** {'price': 116.05, 'previousClose': 118.8, 'change': -2.31} (Change of -2.31)
*   **5-Day Moving Average:** 121.928
*   **20-Day Moving Average:** 113.0605
*   **60-Day Moving Average:** 124.0315

**Analysis:** The current price is below both the 5-day and 60-day moving averages but above the 20-day moving average. The recent price decrease of -2.31 from the previous close suggests a slight downward trend in the very short term.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3318 (Low Risk)
*   **RSI:** 55.46 (Neutral)
*   **PPO:** 1.47
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Divergence Change:** 3.7 (+): Short-term Increase
*   **Expected Return:** 56.3% (Over S&P 500, long-term, based on current valuation)

**Analysis:** The MRI suggests low market risk. The RSI indicates a neutral momentum. The PPO is above zero, suggesting that the short-term moving average is above the long-term moving average. The Hybrid Signal suggests buying a portion of available cash. The recent increase in relative divergence indicates short-term positive momentum. The expected return is a substantial premium to the S&P 500, suggesting a potentially attractive long-term investment opportunity.  The price drop of -2.31 should be considered in conjunction with these indicators; while the MRI indicates low risk, the price movement requires attention.

**4. Recent News & Significant Events**

*   **2025-08-08:** Major business developments, regulatory changes, or market events.
*   **2025-08-06:** Analyst discussions on performance and outlook.
*   **2025-08-07:** Notable stock volatility due to recent news.
*   **2025-08-04:** Market experts highlight risks and opportunities.

**Analysis:** The recent news suggests increased activity and scrutiny surrounding TMDX, with potential volatility. Investors should monitor news and company announcements closely.

**5. Recent Earnings Analysis**

| Date       | EPS   | Expected EPS |
| :---------- | :----- | :------------- |
| 2025-07-30 | 0.92 | 0.48         |
| 2025-05-08 | 0.70 | 0.29         |
| 2025-02-27 | 0.19 | 0.22         |
| 2024-10-28 | 0.12 | 0.29         |
| 2024-07-31 | 0.35 | 0.21         |

**Analysis:** TMDX has consistently exceeded EPS expectations in recent quarters, signaling strong financial performance. The increasing trend in EPS is a positive sign. The outlier from 2024-10-28 should also be noted.

**6. Financial Information**

*   **Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
| :----------- | :-------- | :-------------- |
| 2025-06-30 | $0.16B | 61.38%       |
| 2025-03-31 | $0.14B | 61.47%       |
| 2024-12-31 | $0.12B | 59.21%       |
| 2024-09-30 | $0.11B | 55.94%       |
| 2024-06-30 | $0.11B | 60.59%       |

*   **Capital and Profitability:**

| Quarter      | Equity  | ROE     |
| :----------- | :-------- | :-------- |
| 2025-06-30 | $0.32B | 10.97% |
| 2025-03-31 | $0.27B | 9.64%  |
| 2024-12-31 | $0.23B | 3.00%  |
| 2024-09-30 | $0.21B | 2.01%  |
| 2024-06-30 | $0.19B | 6.42%  |

**Analysis:** Revenue is growing steadily, and the profit margin is exceptionally high. Equity is increasing, and ROE has shown significant improvement, particularly in the most recent quarters.

**7. Overall Assessment**

Transmedics Group Inc. (TMDX) demonstrates strong performance characteristics:

*   **Exceptional Outperformance:**  Significantly exceeding the S&P 500.
*   **High Volatility:** Beta and MDD indicate substantial price swings.
*   **Strong Financials:** Increasing revenue, high profit margins, and improving ROE.
*   **Positive Earnings:** Consistently beating EPS expectations.
*   **Low Market Risk:** Current MRI suggests a relatively safe market environment.
*   **Recent Volatility:** Recent price movements and news indicate possible short-term turbulence.
*   **High Growth Potential:** Analyst discussions on performance and outlook,  Expected Return: 56.3%

**Recommendation:**

Based on the information provided, TMDX presents an interesting investment opportunity, especially for those seeking growth potential. However, the high volatility and recent market activity require careful consideration.
